MAHA peptide push?

Honestly, the current setup feels almost ideal to me. Anyone willing to dig into this stuff can decide for themselves what to introduce into their body. Meanwhile, those with no clue can't get their hands on medicine that might be risky.

That said, it would be great if pricing held steady and there were stronger assurances regarding purity and safety.

If peptides got folded into the US healthcare system, the likely outcome is a prescription requirement and a monthly cost of $200+ for what grey sellers offer as a $100 kit.
 
As long as the market stays open the way it is now — no prescription requirement, no massive costs — I'm fine with this.
 
Honestly, the current setup suits me fine. If someone puts in the effort to research peptides, they can buy them; if they haven't got a clue what they're doing, they probably won't stumble into it. The real problem is inconsistent quality — sure, stronger safety rules would be a plus.

My worry is that bringing all of this under medical control would make prices jump two or three times overnight. That's the usual pattern: a $100 kit becomes a $200+ prescription, and nobody wins there.

The piece makes it clear just how chaotic this area is, but in my view, preserving open access while raising quality beats putting everything behind a prescription.
 
“The FDA’s aim is for patients to be able to obtain products that FDA has approved, and where those aren’t available or don’t work for a particular patient, [that they] are supplied by licensed U.S. pharmacies, prescribed by a physician and manufactured to proper quality standards — rather than coming from foreign or unregulated sources that could carry safety risks,” spokesperson standards — Emily Hilliard said in an email."

The FDA can back right off. When it comes to the agency and yet more regulation, I'm past cynical. I will never accept that the FDA exists for our safety — it's a vast bureaucracy staffed by bureaucrats and bankrolled by pharma money. Pay to play.
 
FarmgirlRebel said:

“The FDA’s aim is for patients to be able to obtain products that FDA has approved, and where those aren’t available or don’t work for a particular patient, [that they] are supplied by licensed U.S. pharmacies, prescribed by a physician and manufactured to proper quality standards — rather than coming from foreign or unregulated sources that could carry safety risks,” spokesperson standards — Emily Hilliard said in an email."

The FDA can back right off. When it comes to the agency and yet more regulation, I'm past cynical. I will never accept that the FDA exists for our safety — it's a vast bureaucracy staffed by bureaucrats and bankrolled by pharma money. Pay to play.

My feelings match this precisely. When it comes to gray, I'll roll the dice.
 
Thanks for every one of the responses. I can't express strongly enough that when it comes to the way things stand right now with nearly everything in the gray world, I'm 100% on board — "a-ok, just fine" sums it up for me. What I want is to keep getting my research material without the government putting obstacles in the way, since it's obvious that my own health and well being isn't anywhere near the top of its list of priorities (and honestly, it shouldn't be). Thank you!
 
Back
Top